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The global burden of headache is very large, but knowledge of it is far from complete and needs still to be
gathered. Published population-based studies have used variable methodology, which has influenced findings and
made comparisons difficult. The Global Campaign against Headache is undertaking initiatives to improve and
standardize methods in use for cross-sectional studies. One requirement is for a survey instrument with proven
cross-cultural validity. This report describes the development of such an instrument. Two of the authors developed
the initial version, which was used with adaptations in population-based studies in China, Ethiopia, India, Nepal,
Pakistan, Russia, Saudi Arabia, Zambia and 10 countries in the European Union. The resultant evolution of this instrument
was reviewed by an expert consensus group drawn from all world regions. The final output was the Headache-Attributed
Restriction, Disability, Social Handicap and Impaired Participation (HARDSHIP) questionnaire, designed for application by
trained lay interviewers. HARDSHIP is a modular instrument incorporating demographic enquiry, diagnostic questions
based on ICHD-3 beta criteria, and enquiries into each of the following as components of headache-attributed burden:
symptom burden; health-care utilization; disability and productive time losses; impact on education, career and earnings;
perception of control; interictal burden; overall individual burden; effects on relationships and family
dynamics; effects on others, including household partner and children; quality of life; wellbeing; obesity as a comorbidity.
HARDSHIP already has demonstrated validity and acceptability in multiple languages and cultures. Modules may be
included or not, and others (eg, on additional comorbidities) added, according to the purpose of the study and resources
(especially time) available.
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The global burden of headache is very large [1-4]. The
Global Burden of Disease Survey 2010 (GBD2010) con-
firmed that headache disorders are among the top 10
causes of disability worldwide [4], a finding foreseen by
Stovner et al. several years earlier [3]. It is, paradoxically,
a burden widely ignored [5]. The following conclusion
appeared in the Atlas of Headache Disorders and* Correspondence: t.steiner@imperial.ac.uk
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Health Organization (WHO) [6]:
“The facts and figures [on headache] illuminate
worldwide neglect of major causes of public ill-health,
and the inadequacies of responses to them in coun-
tries throughout the world.”
Reduction of the burden of headache worldwide is the
central purpose of the Global Campaign against Head-
ache [1,2,7], conducted by Lifting The Burden (LTB), a
UK-registered nongovernmental organization, in official
relations with WHO. The Campaign’s objectives requiren Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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knowledge. The knowledge base is evidence of the levels,
nationally and worldwide, of headache-related ill-health
and health-care need; it shows what manner of change –
and how much – is required; it supports the humanitarian,
economic and political arguments for change; and it sig-
nals the priority that should be accorded to action for
change. The knowledge base is the foundation on which
everything must be built; it needs to be complete, and
sound. Unfortunately it is not.
The known epidemiology of headache disorders was col-
lated in 2007 [3], the process revealing that prevalence was
often studied without assessment of attributable burden,
that rather little was known of disorders other than mi-
graine and that there was a serious lack of studies of child-
hood and adolescent headache. Perhaps more tellingly than
all of these, the very large geographical gaps – regions
where very little or nothing at all was known of headache
in the population – embraced more than half the people in
the world. Many of these gaps remained when the evidence
was adduced for GBD2010. Furthermore, wide variations in
findings among the published studies were clearly influ-
enced by their methodological differences [3,8].
The Global Campaign began to address these deficien-
cies several years ago, planning population-based studies
in Georgia [9], India [10], China [11], Russia [12] and
Pakistan [13], in Ethiopia, Guatemala, Nepal, Saudi Arabia
and Zambia (in progress or analysis), and in Morocco,
Egypt, Peru and Sri Lanka (planned), and providing intel-
lectual support for the 10-country Eurolight project [14].
These major undertakings focused on the primary head-
ache disorders, essentially migraine and tension-type head-
ache (TTH), which have public-health importance by virtue
of being common, ubiquitous, disabling and, to a large ex-
tent, treatable. Medication-overuse headache (MOH), sec-
ondary by definition [15], was always included because, on
present understanding, it arises mostly if not entirely
through mistreatment of these primary headache disorders.
Unquestionably, MOH contributes to public ill-health; at
individual level, it is more costly even than migraine [16].
In the course of planning these studies, Lifting The Burden
and its collaborators developed both a standardized proto-
col and a survey instrument, and tested them empirically,
the latter in multiple languages. Here we describe the gen-
esis of the survey instrument, and its evolution into the
Headache-Attributed Restriction, Disability, Social Handi-
cap and Impaired Participation (HARDSHIP) question-
naire. Validation studies are reported elsewhere [11-13].
Methods
The process was led by TJS and LJS who, with help from Dr
Tarun Dua, Department of Mental Health and Substance
Abuse, World Health Organization, conceived the first
draft, suggested the areas of enquiry, proposed the questionstructure and phrasing and established a design template.
As population-based studies were planned and undertaken,
and in consultation with a wide range of experts and local
investigators from over 20 countries, the instrument was
amended, expanded through a process of item development
and refined through item rejection based on empirical
experience. Some questions were rephrased. The studies
provided a continuing learning experience, fostering im-
provements through a series of plan-do-study-act cycles,
and were a highly influential part of the development
process.
During this process, the diagnostic questions were the
subject of several validation studies, now completed in
India [10] (translated into Kannada), China [11] (trans-
lated into Mandarin Chinese), Russia [12] (translated into
Russian) and Pakistan [13] (translated into Urdu). Others
are ongoing, including a study in Saudi Arabia using an
Arabic translation. In each of these, questionnaire-derived
diagnoses were compared with “gold-standard” diagnoses
made by headache experts, in most cases in a subset of
participants in a nationwide study.
In the context of a separate undertaking – to develop
guidelines for the conduct and quality-assessment of
population-based burden-of-headache studies – LJS and
TJS convened an expert consensus group [8]. Members
were selected with two considerations in mind: to include
theoretical and/or practical experience and competence in
headache epidemiology, and to ensure international and
cross-cultural relevance. To the latter end, members were
drawn from all six of the WHO world regions. This group
(included among the authors) first acted as a sounding
board and second, and very importantly, reviewed the
structure, design and content of the instrument at a con-
sensus meeting in Trondheim in September, 2011.
Results
The HARDSHIP questionnaire (Additional file 1) is a
structured questionnaire which may be administered by
medical or (more usually) trained lay interviewers. It has
a modular design: separate question sets cover demo-
graphic characteristics, screen for caseness (headache
disorder present or not), diagnose headache type and ad-
dress each of the several quantifiable components of
burden. Headache occurring on ≥15 days/month, includ-
ing MOH, is separated from episodic headache. The
likelihood of multiple headache types occurring in a sin-
gle respondent is recognized, and the potential confu-
sion arising therefrom is minimized by asking him or
her to identify, and focus upon, the one that is subject-
ively the most bothersome. Diagnostic questions based
on the criteria of the International Classification of
Headache Disorders, 3rd edition beta version (ICHD-3
beta) [17], and enquiries into burden, are directed at this
headache type. Responses to the diagnostic questions are
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file 2); diagnoses are not made by the interviewer(s).
The diagnostic validation studies from India [10], China
[11], Russia [12] and Pakistan [13] produced the results
shown in Table 1. In all studies, sensitivity was better for
migraine than for TTH.
Separate modules (each of which may be included or
not according to study purpose, time constraints, re-
sources available and cultural appropriateness) cover the
following aspects of headache-attributed burden: symp-
tom burden; health-care utilization; disability and pro-
ductive time losses; impact on education, career and
earnings; perception of control; interictal burden; overall
individual burden (as willingness to pay for treatment);
effects on relationships, love life and family dynamics;
effects on others, including household partner and chil-
dren; quality of life; wellbeing; obesity as a comorbidity.
Discussion
Demographic enquiry is essential to characterize the
sample. Data are needed in order to compare those who
have been selected with the population of interest from
whom they are drawn and of whom they are intended to
be representative. While, ideally, these data will reflect
all factors that may influence prevalence and/or burden
of headache, this objective is necessarily limited by the
availability of data characterizing the entire population.
National (but perhaps not regional) statistics are com-
monly available for gender and age distributions. Even
when they are not, these are of such prime importance
in headache epidemiology that they must be known in
the sample. Social situation (especially wealth), habita-
tion (urban or rural) and ethnicity and/or culture may
be important influencers of prevalence or burden, and
are therefore of some interest.
Diagnosis must follow ICHD criteria [17] because these
are the common language of definition and description of
headache disorders [18]. There is no alternative, even
though ICHD criteria were not designed for epidemio-
logical enquiry and are not particularly well-suited to it
[18]. For epidemiological purposes, these criteria must be
built into a structured questionnaire, although this is not
how diagnoses are usually made in clinical settings. OpenTable 1 Sensitivities, specificities, positive (PPV) and negative
“gold-standard” diagnoses (kappa), of the diagnostic questio
Study Migraine
Sensitivity Specificity PPV NPV K
India [10]1 0.63 0.85 0.55 0.89
China [11]2 0.83 0.99 0.83 0.99
Russia [12]3 0.77 0.82 0.69 0.87
Pakistan [13]4 0.74 0.87 0.60 0.92
1Translated into Kannada; 2translated into Mandarin Chinese; 3translated into Russiaquestions are difficult to interpret and categorize, and do
not permit algorithmic determination.
Certain criteria distinguishing between migraine and
TTH pose particular problems in population surveys
[18]. First, empirically it has been found difficult to
gather correct responses on headache duration [3], re-
quiring patients to consider untreated attacks, which
they may never have or last had long ago. This results in
a high proportion of probable diagnoses because dur-
ation criteria appear unfulfilled [18]. Second, there are
no easy lay explanations of photo- and phonophobia,
which are technical concepts, and even more difficult is
to specify what degrees of photo- and phonophobia fulfil
migraine criteria in ICHD [18]. False-positive responses,
more likely when answers are forced (without the re-
sponse option of “don’t know”, which is diagnostically
unhelpful), push diagnoses towards migraine. HARD-
SHIP includes a “not sure” option and applies a rule that
“not sure” implies absence of the symptom. The reasoning
is that presence of a symptom creates a definite awareness
of it, and only its absence allows uncertainty. This sug-
gested approach requires further empirical testing.
MOH is diagnosable in cross-sectional studies only as
an association of medication overuse with frequent
headache (there is no evidence available of causation)
[18]. Therefore, all such cases are probable MOH, and it
is important to recognize this limitation during analyses
and interpretation.
Symptoms of common headache disorders include pain,
and, of migraine, nausea, vomiting and photo- and/or
phonophobia. Symptom burden is addressed in HARD-
SHIP by questions 14, 15, 20, 21/23, 24, 29–32, 36 and 37.
Pain can be quantified at individual level as a product of
intensity, frequency and duration, and at population level
as the product of the average among individuals and
prevalence. Nausea, photophobia and phonophobia are al-
most impossible to quantify, but their occurrence can be
recorded and frequencies expressed.
Disability attributed to headache is also difficult to
quantify completely. Common proxies are lost time and
reduced productivity, for which well-validated instruments
exist [19,20]. HARDSHIP (questions 38–44 and 58–62)
imports the Headache-Attributed Lost Time (HALT)(NPV) predictive values, and overall agreement with
n set for migraine and tension-type headache
Tension-type headache
appa Sensitivity Specificity PPV NPV Kappa
0.46 0.57 0.81 0.61 0.79 0.39
0.82 0.51 0.99 0.86 0.92 0.59
0.58 0.64 0.91 0.86 0.74 0.56
0.56 0.60 0.92 0.69 0.88 0.54
n; 4translated into Urdu.
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questions have commonly been limited to a 3-month
timeframe [19,20] as a compromise between the limits
of recall and the purpose of enquiry. When the latter is
the assessment of an individual patient for therapeutic
reasons, the period must be long enough to be representa-
tive of that individual. In large-group studies, this is
quite unnecessary: different considerations apply, because
population- rather than individual-representativeness is
sought. Variations of HALT that record over shorter time-
frames of one month (HALT-30) and one week (HALT-7)
are being tested empirically [21].
Enquiry into headache yesterday (effectively HALT-1)
(HARDSHIP questions 34–45) avoids recall problems al-
most altogether [18,22]. It cannot describe the propor-
tion of the population with an active headache disorder,
but it yields very accurate information on burden in each
individual and, potentially, a rather precise estimate of
population burden on a particular day and, therefore, on
any day (assuming no major seasonal variation). A large
sample is necessary, because 1-day prevalence of epi-
sodic headache disorders is obviously much lower than
1-year prevalence. This module probably should not be
used except in an unscheduled interview (face-to-face or
telephone) [18]; if it is received by a person with head-
ache on that day, he or she may well postpone answering
it until their next headache-free day.
Interictal burden (HARDSHIP questions 64–66) arises
because headache attacks are unpleasant, and those who
experience them frequently are likely to worry about
when the next may occur, and/or attempt to eliminate
possible triggers through lifestyle compromise. Interictal
burden, which is continuous, is likely to affect subjective
wellbeing and may be sufficient to impair quality of life.
It is perhaps adequately, if not specifically, captured by
measures of subjective wellbeing and quality-of-life mea-
sures. HARDSHIP imports, as modules, WHOQoL-8
[23] (questions 90–97) and the four questions on sub-
jective wellbeing taken from the UK-ONS 2012 survey
[24] (98–101).
Cumulative burden (HARDSHIP questions 51–57), ac-
cruing over a lifetime, cannot be fully assessed until late
in a lifetime. Furthermore, attribution may be uncertain.
Nevertheless, a consequence of recurring inability to
work may be decreased probability of promotion, and a
consequence of lost school-time may be reduced career
opportunities. These may be heavy burdens.
An overall summary measure of individual burden is un-
likely to be comprehensive, but the concept is attractive for
its simplicity [18]. One such measure is willingness-to-pay
(WTP) (HARDSHIP questions 67–74). Its reliability as a
burden measure remains unclear: its hypothetical nature al-
lows a potential disconnection between what respondents
say they will pay and what they actually will pay whenconfronted by the reality, and of course WTP is constrained
by ability to pay. Nevertheless, this form of enquiry has
been used to assess sustainability of health-care initiatives
in resource-poor countries [25].
Burden on others, unaffected by headache themselves, is
addressed by HARDSHIP questions 75–86. Subjective in-
terpretations are unavoidable. A full account necessitates
enquiries among the others, which in practical terms may
be possible only among close family members.
Health-care resource consumption (HARDSHIP ques-
tions 45–50) is relatively easy to enquire into, but sub-
ject to recall bias. It should also be easy to establish who
pays for it (the patient, employer, insurer or society via
the State). It is less easy to attach accurate costs to indi-
vidual items of health care, and this may necessitate sep-
arate research into health-care costs in the country or
region in question [16].
By far the greater part of the financial cost of headache
is the indirect cost of absenteeism and reduced effective-
ness at work [16,26] (HARDSHIP questions 58 and 59).
This cost may be borne by individuals, but commonly
falls upon employers and/or insurers, and is a cost to na-
tional economies (societal economic burden).
Enquiry into comorbidity includes body mass index
(HARDSHIP questions 87–89), since obesity may be an
important and potentially remediable risk factor for fre-
quent headache [27]. Other (for example, psychiatric)
comorbidities can be included by bringing in other in-
struments (eg, the Hospital Anxiety and Depression
Scale [28], or the Shona Symptom Questionnaire [29],
which may be better suited to some cultures).
The strengths of HARDSHIP are several. First, a very
broad base of expert opinion contributed to its evolu-
tion. Second, it has undergone testing in many cultures
and settings: so far in 19 countries and 18 languages. In
some countries within the Eurolight study [14], rather
than being administered by interviewer as envisaged in
its development, it was mailed or handed out for self-
completion. Third, its successful employment in multiple
studies has built a collection of studies conducted with
similar methodology in different world regions, facilitat-
ing inter-regional comparisons. Likewise, its use in fu-
ture studies will enable further comparisons. Fourth, its
modular design renders it highly amenable to adaptation
to suit purpose, resource availability (especially time)
and cultural sensitivities.
The one known limitation, discovered empirically, is
that the diagnostic question set is relatively insensitive
to TTH in all languages and cultures in which it has
been tested. The problem is attributable partly to these
questions being necessarily tied to ICHD, which makes
it difficult to resolve because there is very limited scope
for change. More particularly, though, it is due to the
nature of TTH itself. Being usually a mild-to-moderate
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ported. Beyond this, because it lacks specific features, it
is diagnosed through absence of the features characteris-
tic of migraine, and therefore effectively by default. Re-
duced sensitivity is inevitable in such circumstances. In
this context it is worth noting that, uniquely among the
so far reported studies using HARDSHIP, the population
survey in China was conducted by physicians. For mi-
graine, the diagnostic question set performed best in
China (Table 1) but, for TTH, sensitivity remained low.
In the studies conducted using HARDSHIP, migraine
prevalence has been high, although not in China (1-year
prevalence 9.3% [30]), where headache generally appears
less prevalent. In Russia the reported 1-year prevalence is
20.8% [31]; in India (Karnataka State) it is over 25% [un-
published]; in other countries not yet reported, levels of
this order have been found. There are two possible expla-
nations of this. First is that some cases of TTH are incor-
rectly diagnosed as migraine, a possibility suggested by the
low sensitivity to TTH just referred to. Second is that
these findings reflect the truth, and that migraine is more
common than has been thought (global 1-year prevalence
about 11% [3]). We suggest that careful enquiry observes
a higher prevalence of migraine by capturing milder cases
(ie, by better case ascertainment), and that, although both
of these explanations may contribute in part, migraine is
indeed more prevalent than past estimates have suggested.
Alstadhaug et al. [32] reported the prevalence of mi-
graine in Norwegian neurologists, among whom diagno-
ses should be correct and case ascertainment very high.
The age-adjusted 1-year prevalence of migraine headache
(ie, excluding cases of aura only) was 26.3% (95% CI: 18.5-
34.2%), 15.9% in males and 36.7% in females. It is unlikely
that Norwegian neurologists are biologically unique.
Conclusions
For better and comparable population-based studies of
the burden of headache, there is a clear need for a survey
instrument with proven cross-cultural validity, adaptable
to the circumstances of particular studies and resource-
availability [8]. HARDSHIP has demonstrated validity and
acceptability in multiple languages and cultures. Modules
may be included or not, and others (eg, on comorbidities)
added, according to the purpose(s) of the study.
Additional files
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